What is LuZa?
LuZa positions itself as the nation's sole Cannabinoid Compounder, emphasizing a personalized approach to wellness. The company focuses on creating custom CBD and cannabinoid formulas tailored to individual needs, diverging from mass-market solutions. This bespoke strategy aims to address specific consumer requirements in the burgeoning cannabinoid market.
How much funding has LuZa raised?
LuZa has raised a total of $10K across 1 funding round:
Debt
$10K
Debt (2021): $10K with participation from PPP
What's next for LuZa?
Operating at a Series A/B growth stage, LuZa's recent acquisition of moderate growth capital suggests a strategic push towards scaling its operations and expanding its market reach. The company is likely to leverage this investment to enhance its compounding capabilities, broaden its product development, and strengthen its distribution channels. Future developments may include further research into novel cannabinoid applications and strategic partnerships to solidify its unique market position.
See full LuZa company page